Objective To explore the impact of maternal sex chromosome aneuploidies (SCAs) and copy
number variation (CNV) on false‐positive results of non‐invasive prenatal screening (NIPS) …

Objective To assess the accuracy of fetal sex determination at 11–14 weeks of gestation.
Methods Fetal gender assessment by ultrasound was prospectively carried out in 172 …

Objective: This study was designed to investigate the efficiency of noninvasive prenatal
testing (NIPT) for screening fetal sex chromosome aneuploidies (SCAs) through sequencing …

Objectives To evaluate in twin pregnancy the utility of non‐invasive prenatal testing using
circulating cell‐free fetal DNA (cfDNA) in screening for the three main autosomal fetal …

Objective: The aim of this work was to investigate the association between maternal and
fetal characteristics and the fetal fraction at 8–14 weeks' gestation, with emphasis on the …

Objective To explore the feasibility of routine maternal blood cell‐free (cf) DNA testing in
screening for trisomies 21, 18 and 13 at 10 weeks' gestation. Method In this prospective …

Noninvasive prenatal testing (NIPT) using cell‐free DNA (cfDNA) from maternal serum has
been clinically available since 2011. This technology has revolutionized our ability to screen …

Objective To review the performance of non‐invasive prenatal testing (NIPT) by low‐
coverage whole‐genome sequencing of maternal plasma DNA at a single center. Methods …

A new technology, noninvasive prenatal testing (NIPT), can identify fetal sex early in
pregnancy, five weeks after conception, with a high degree of accuracy through analysis of …

Objective To examine the positive predictive value (PPV) of cfDNA screening for sex
chromosome aneuploidies (SCA) in a large series of over 90 000 patients. Methods …